1. Concept
SHPS1 (Src Homology Region 2 Domain-Containing Phosphatase Substrate 1) is a key transmembrane molecule in cell signaling, widely expressed across cell types with prominent roles in immune cells. As a member of the phosphatase receptor family, it features a glycosylated extracellular N-terminal region and a C-terminal intracellular domain with phosphorylation sites and immunoreceptor tyrosine inhibitory motifs (ITIM).

These structural traits enable SHPS1 to interact with multiple signaling molecules, including Src kinase family members and phosphatases like SHP-1 and SHP-2. By binding SH2 domain-rich proteins, SHPS1 modulates diverse cell signaling pathways, regulating immune cell activation, migration, and cytokine secretion. Its functions span immune response balance, tumor immune evasion, neurological signal transmission, and autoimmune disease pathogenesis, making it a versatile and critical molecule in biological processes.
2. Research Frontiers
SHPS1 research is advancing across immunology, oncology, neuroscience, and autoimmune disease fields. A key frontier is dissecting the SHPS1-SHP-1/SHP-2 signaling axis in tumor immune evasion, with preclinical studies testing monoclonal antibodies and small molecules to block this interaction and restore anti-tumor immunity.

In neuroscience, emerging research focuses on SHPS1’s role in synaptic plasticity and neurodegenerative diseases, exploring its potential as a therapeutic target for Alzheimer’s. In autoimmune diseases, studies use SHPS1 modulation to restore immune tolerance, with applications in rheumatoid arthritis and systemic lupus erythematosus.

Technological innovations include single-cell sequencing to map tissue-specific SHPS1 regulatory networks, and high-resolution imaging to visualize dynamic signaling interactions. Future directions expand to combination immunotherapies (e.g., SHPS1 inhibitors + PD-1 antibodies) and multifunctional targeted drugs, leveraging AI-driven design for precision.

3. Research Significance
SHPS1’s significance lies in its central role as a signaling hub bridging immunity, tumor biology, neuroscience, and autoimmune diseases. In oncology, targeting the SHPS1-CD47 axis offers a novel immunotherapeutic strategy to overcome tumor evasion. In immunology, it regulates immune cell balance, providing insights into both immune deficiency and autoimmunity.

In neuroscience, SHPS1’s impact on synaptic function opens avenues for treating cognitive disorders. Basic research on SHPS1 deepens understanding of intercellular signaling, while translational efforts advance targeted therapies—addressing unmet medical needs in cancer, neurological diseases, and autoimmune disorders.

4. Molecular Mechanisms, Biological Roles, and Product Support
4.1 Molecular Structure and Signaling Mechanisms
4.1.1 Core Structural Features
Extracellular Region: Glycosylated N-terminal domain mediates ligand binding (e.g., CD47).
Intracellular Domain: Contains ITIM motifs and phosphorylation sites that recruit SH2 domain-containing proteins (SHP-1, SHP-2, Src kinases).

4.1.2 Signaling Pathways
SHPS1 transmits signals primarily via two mechanisms:
Inhibitory Signaling: Binding to CD47 recruits SHP-1/SHP-2, dephosphorylating downstream molecules to inhibit immune cell activation (e.g., macrophage phagocytosis).
Modulatory Signaling: Interacts with Src kinases and PI3Kγ to regulate cell migration, maturation, and cytokine secretion in immune and neural cells.

4.2 Biological Roles of SHPS1
4.2.1 Immune System Regulation
Immune Evasion: Tumor cells exploit the SHPS1-CD47 interaction to suppress macrophage and T cell activity, evading immune surveillance. Blocking this axis enhances anti-tumor immunity.
Dendritic Cell Function: SHPS1 regulates dendritic cell maturation and antigen presentation, influencing the initiation of primary immune responses.
Macrophage Regulation: Modulates macrophage phagocytosis and cytokine release, balancing inflammatory responses to prevent excessive tissue damage.

4.2.2 Tumor Immune Evasion
SHPS1 plays a pivotal role in tumor progression by inhibiting immune cell function. Tumor cell-expressed CD47 binds SHPS1 on immune cells, recruiting SHP-1/SHP-2 to suppress activation signals, reducing cytokine secretion and phagocytosis. This mechanism enables tumors to escape host immunity, making SHPS1 a key target for immunotherapy.
4.2.3 Nervous System Function
Synaptic Plasticity: SHPS1 regulates signal transmission between neurons, influencing memory formation and learning ability. Deficiency leads to synaptic plasticity defects and cognitive impairment.
Neurodegenerative Diseases: Abnormal SHPS1 expression is linked to neuronal dysfunction in Alzheimer’s disease, offering a potential therapeutic target to slow disease progression.

4.2.4 Autoimmune Diseases
SHPS1 dysregulation contributes to immune tolerance loss. In rheumatoid arthritis and systemic lupus erythematosus, altered SHPS1 function exacerbates immune cell attacks on self-tissues. Modulating SHPS1 activity restores immune balance, providing a new treatment strategy for these diseases.

4.3 How ANT BIO PTE. LTD. Products Support SHPS1 Research
ANT BIO PTE. LTD., through its sub-brand Starter (specializing in antibodies), provides high-quality reagents to study SHPS1-mediated signaling pathways.

Key products and applications:
S0B1093 (Phospho-SHP-2 (Tyr542) Recombinant Rabbit mAb): Detects phosphorylated (active) SHP-2, a key downstream effector of SHPS1. Ideal for verifying SHPS1 signaling activation in immune cells, tumor models, or neural tissues.
S0G0015 (Phospho-SHP-2 (Tyr542) Antibody Duo): Offers complementary tools for confirming SHP-2 phosphorylation, supporting Western blotting, immunofluorescence, and co-immunoprecipitation assays to study SHPS1-SHP-2 interactions.

Both products ensure high specificity, affinity, and consistency—critical for reproducible signaling pathway analysis and drug screening in SHPS1 research.

5. Brand Mission
ANT BIO PTE. LTD. is dedicated to empowering the global life science community with high-quality, innovative biological reagents and solutions. With 15 years of antibody development experience, the company leverages advanced platforms—including recombinant antibody development (rabbit/mouse monoclonal), recombinant protein development systems (E.coli, CHO, HEK293, Insect Cells), One-Step ELISA, and PTM Pan-Modification Antibody platforms—to deliver a comprehensive product portfolio.

Through its three specialized sub-brands—Absin (general reagents and kits), Starter (antibodies), and UA (recombinant proteins)—ANT BIO PTE. LTD. adheres to international certifications (EU 98/79/EC, ISO9001, ISO13485) and strict quality standards. The company’s mission is to accelerate scientific discovery by providing tools that enhance experimental precision, efficiency, and reproducibility. ANT BIO PTE. LTD. is committed to supporting SHPS1 research and global efforts in immunotherapy, neurodegenerative disease treatment, and autoimmune disorder management, ultimately advancing human health through interdisciplinary collaboration and innovation.

6. Related Product List

Product Code	Product Name
S0B1093	Phospho-SHP-2 (Tyr542) Recombinant Rabbit mAb (S-1254-13)
S0G0015	Phospho-SHP-2 (Tyr542) Antibody Duo

7. AI Disclaimer
This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.
 
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.